ImmunoGen immunogen.com


ImmunoGen (IMGN) is a biotechnology company focused on the development of antibody-drug conjugate therapeutics for the treatment of cancer.

ImmunoGen (IMGN) is a biotechnology company focused on the development of antibody-drug conjugate therapeutics for the treatment of cancer.

Company (IPO / Went public)

Phone: 781-895-0600

Fax:

830 Winter Street

Waltham, 02451
Massachusetts, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
ImmunoGen $0M Nov 21, 2018

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related ImmunoGen Jobs

jobs by Indeed job
						search
There is no Investors data available for this company. Please select another tab.
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Cytotoxic benzodiazepine derivatives Mar 31, 2017 May 22, 2018 Patent
Preparation of maytansinoid antibody conjugates by a one-step process Jul 21, 2016 Mar 13, 2018 Patent
Conjugates comprising cell-binding agents and cytotoxic agents Feb 28, 2014 Feb 27, 2018 Patent
Methods of preparing cytotoxic benzodiazepine derivatives Jul 21, 2016 Feb 13, 2018 Patent
Methods of preparing cytotoxic benzodiazepine derivatives Jul 21, 2016 Jan 23, 2018 Patent
See all 185 patents